{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T01:30:09Z","timestamp":1790127009922,"version":"4.0.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T00:00:00Z","timestamp":1755907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Qihang Funds of Fujian Medical University","award":["2023QH2050"],"award-info":[{"award-number":["2023QH2050"]}]},{"name":"Qihang Funds of Fujian Medical University","award":["2022QH2048"],"award-info":[{"award-number":["2022QH2048"]}]},{"name":"Major Scientific Research\u00a0Program for\u00a0Young\u00a0and Middle-aged Health Professionals of\u00a0Fujian Province, China","award":["2021ZQNZD010"],"award-info":[{"award-number":["2021ZQNZD010"]}]},{"name":"High-level Talent Training Program of Fujian Cancer Hospital","award":["2022YNG07"],"award-info":[{"award-number":["2022YNG07"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Oral Health"],"DOI":"10.1186\/s12903-025-06733-5","type":"journal-article","created":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T07:20:10Z","timestamp":1755933610000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic implications of EBER and EBV DNA combinations in nasopharyngeal carcinoma in endemic areas"],"prefix":"10.1186","volume":"25","author":[{"given":"Ying","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lishui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongwei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunqiu","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghua","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sufang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,23]]},"reference":[{"key":"6733_CR1","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1007\/s10555-024-10176-9","volume":"43","author":"ZY Su","year":"2024","unstructured":"Su ZY, Siak PY, Lwin YY, Cheah SC. Epidemiology of nasopharyngeal carcinoma: current insights and future outlook. Cancer Metastasis Rev. 2024;43:919\u201339.","journal-title":"Cancer Metastasis Rev"},{"key":"6733_CR2","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0140-6736(19)30956-0","volume":"394","author":"YP Chen","year":"2019","unstructured":"Chen YP, Chan ATC, Le QT, et al. Nasopharyngeal carcinoma. Lancet. 2019;394:64\u201380.","journal-title":"Lancet"},{"key":"6733_CR3","doi-asserted-by":"publisher","first-page":"1079515","DOI":"10.3389\/fimmu.2022.1079515","volume":"13","author":"W Li","year":"2023","unstructured":"Li W, Duan X, Chen X, et al. Immunotherapeutic approaches in EBV-associated nasopharyngeal carcinoma. Front Immunol. 2023;13:1079515.","journal-title":"Front Immunol"},{"key":"6733_CR4","doi-asserted-by":"publisher","first-page":"1116143","DOI":"10.3389\/fmicb.2023.1116143","volume":"14","author":"ZY Su","year":"2023","unstructured":"Su ZY, Siak PY, Leong CO, Cheah SC. The role of Epstein-Barr virus in nasopharyngeal carcinoma. Front Microbiol. 2023;14:1116143.","journal-title":"Front Microbiol"},{"key":"6733_CR5","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/s41418-022-00939-8","volume":"29","author":"L Yuan","year":"2022","unstructured":"Yuan L, Li S, Chen Q, et al. EBV infection-induced GPX4 promotes chemoresistance and tumor progression in nasopharyngeal carcinoma. Cell Death Differ. 2022;29:1513\u201327.","journal-title":"Cell Death Differ"},{"key":"6733_CR6","doi-asserted-by":"publisher","first-page":"11720","DOI":"10.3390\/ijms231911720","volume":"23","author":"JM Dias","year":"2022","unstructured":"Dias JM, Santana IVV, da Silva VD, Carvalho AL, Arantes L. Analysis of Epstein-barr virus (EBV) and PD-L1 expression in nasopharyngeal carcinoma patients in a non-endemic region. Int J Mol Sci. 2022;23:11720.","journal-title":"Int J Mol Sci"},{"key":"6733_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59010002","volume":"59","author":"N Ahmed","year":"2022","unstructured":"Ahmed N, Abusalah M, Farzand A, et al. Updates on Epstein-Barr virus (EBV)-associated nasopharyngeal carcinoma: emphasis on the latent gene products of EBV. Medicina (B Aires). 2022;59: 2.","journal-title":"Medicina (B Aires)"},{"key":"6733_CR8","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-1-62703-357-2_16","volume":"999","author":"LM Weiss","year":"2013","unstructured":"Weiss LM, Chen YY. EBER in situ hybridization for Epstein-Barr virus. Methods Mol Biol. 2013;999:223\u201330.","journal-title":"Methods Mol Biol"},{"key":"6733_CR9","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens9030226","volume":"9","author":"MAH AbuSalah","year":"2020","unstructured":"AbuSalah MAH, Gan SH, Al-Hatamleh MAI, Irekeola AA, Shueb RH, Yean Yean C. Recent advances in diagnostic approaches for Epstein-Barr virus. Pathogens. 2020;9: 226.","journal-title":"Pathogens"},{"key":"6733_CR10","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","volume":"381","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Chen L, Hu GQ, et al. Gemcitabine and cisplatin induction chemotherapy in nasopharyngeal carcinoma. N Engl J Med. 2019;381:1124\u201335.","journal-title":"N Engl J Med"},{"key":"6733_CR11","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1001\/jama.2022.13997","volume":"328","author":"LL Tang","year":"2022","unstructured":"Tang LL, Guo R, Zhang N, et al. Effect of radiotherapy alone vs radiotherapy with concurrent chemoradiotherapy on survival without disease relapse in patients with low-risk nasopharyngeal carcinoma: a randomized clinical trial. JAMA. 2022;328:728\u201336.","journal-title":"JAMA"},{"key":"6733_CR12","unstructured":"Du XJ, Wang GY, Zhu XD et al. Refining the 8th edition TNM classification for EBV related nasopharyngeal carcinoma. Cancer Cell. 2024;42:464\u201373.e463."},{"key":"6733_CR13","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1002\/hed.26608","volume":"43","author":"ZG Wei","year":"2021","unstructured":"Wei ZG, Hu XL, He Y, et al. Clinical and survival analysis of nasopharyngeal carcinoma with consistently negative Epstein-Barr virus DNA. Head Neck. 2021;43:1465\u201375.","journal-title":"Head Neck"},{"key":"6733_CR14","doi-asserted-by":"publisher","first-page":"3005","DOI":"10.3390\/jcm12083005","volume":"12","author":"Y Xiong","year":"2023","unstructured":"Xiong Y, Yuan M, Liu Z, et al. Long-term outcomes of nasopharyngeal carcinoma by Epstein-Barr virus status in the Chinese population: A multicenter investigation. J Clin Med. 2023;12:3005.","journal-title":"J Clin Med"},{"key":"6733_CR15","doi-asserted-by":"publisher","first-page":"24208","DOI":"10.18632\/oncotarget.8144","volume":"7","author":"H Peng","year":"2016","unstructured":"Peng H, Chen L, Zhang Y, et al. Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status. Oncotarget. 2016;7:24208\u201316.","journal-title":"Oncotarget"},{"key":"6733_CR16","doi-asserted-by":"publisher","first-page":"21976","DOI":"10.1038\/s41598-020-78892-0","volume":"10","author":"D Tao","year":"2020","unstructured":"Tao D, Zhang N, Huang Q, et al. Association of Epstein-Barr virus infection with peripheral immune parameters and clinical outcome in advanced nasopharyngeal carcinoma. Sci Rep. 2020;10:21976.","journal-title":"Sci Rep"},{"key":"6733_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3760\/cma.j.issn.0366-6999.20132206","volume":"127","author":"K Ke","year":"2014","unstructured":"Ke K, Wang H, Fu S, et al. Epstein-Barr virus-encoded RNAs as a survival predictor in nasopharyngeal carcinoma. Chin Med J Engl. 2014;127:294\u20139.","journal-title":"Chin Med J Engl"},{"key":"6733_CR18","doi-asserted-by":"publisher","first-page":"175883592412864","DOI":"10.1177\/17588359241286489","volume":"16","author":"Y Weng","year":"2024","unstructured":"Weng Y, Wu L, Li Y, et al. Prognostic value of immune-inflammatory and nutrition indicators in non-metastatic nasopharyngeal carcinoma with negative plasma Epstein-Barr virus DNA. Ther Adv Med Oncol. 2024;16:17588359241286489.","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"6733_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2407061","volume":"56","author":"Y Li","year":"2024","unstructured":"Li Y, Chen X, Wu L, et al. Impact of the radiotherapy rhythm on prognosis in nasopharyngeal carcinoma. Ann Med. 2024;56(1): 2407061.","journal-title":"Ann Med"},{"key":"6733_CR20","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2016.0270","volume":"372","author":"SW Tsao","year":"2017","unstructured":"Tsao SW, Tsang CM, Lo KW. Epstein-Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc Lond B Biol Sci. 2017;372: 20160270.","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"6733_CR21","doi-asserted-by":"crossref","unstructured":"Lewis JS Jr., Beadle B, Bishop JA, et al. Human papillomavirus testing in head and neck carcinomas: guideline from the college of American pathologists. Arch Pathol Lab Med. 2018;142(5):559\u201397.","DOI":"10.5858\/arpa.2017-0286-CP"},{"issue":"3","key":"6733_CR22","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/cncr.31031","volume":"124","author":"WB Huang","year":"2018","unstructured":"Huang WB, Chan JYW, Liu DL. Human papillomavirus and world health organization type III nasopharyngeal carcinoma: multicenter study from an endemic area in Southern China. Cancer. 2018;124(3):530\u20136.","journal-title":"Cancer"},{"key":"6733_CR23","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1002\/cncr.20099","volume":"100","author":"JY Shao","year":"2004","unstructured":"Shao JY, Li YH, Gao HY, et al. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin a\/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma. Cancer. 2004;100:1162\u201370.","journal-title":"Cancer"},{"key":"6733_CR24","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/ijc.33006","volume":"147","author":"J Simon","year":"2020","unstructured":"Simon J, Schroeder L, Ingarfield K, et al. Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country. Int J Cancer. 2020;147:461\u201371.","journal-title":"Int J Cancer"},{"key":"6733_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.envint.2021.106455","volume":"151","author":"Y Chen","year":"2021","unstructured":"Chen Y, Chang ET, Liu Z, et al. Residence characteristics and risk of nasopharyngeal carcinoma in Southern China: a population-based case-control study. Environ Int. 2021;151: 106455.","journal-title":"Environ Int"},{"issue":"4","key":"6733_CR26","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/ijc.34933","volume":"155","author":"W Di","year":"2024","unstructured":"Di W, Yu J, Zong D, et al. Effects of ambient temperature, relative humidity and absolute humidity on risk of nasopharyngeal carcinoma in China. Int J Cancer. 2024;155(4):646\u201353.","journal-title":"Int J Cancer"},{"key":"6733_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.virusres.2018.04.009","volume":"250","author":"S Wu","year":"2018","unstructured":"Wu S, Liu W, Li H, et al. Conservation and polymorphism of EBV RPMS1 gene in EBV-associated tumors and healthy individuals from endemic and non-endemic nasopharyngeal carcinoma areas in China. Virus Res. 2018;250:75\u201380.","journal-title":"Virus Res"},{"issue":"15","key":"6733_CR28","doi-asserted-by":"publisher","first-page":"2908","DOI":"10.1002\/cncr.34266","volume":"128","author":"SH Huang","year":"2022","unstructured":"Huang SH, Jacinto JCK, O\u2019Sullivan B, et al. Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort. Cancer. 2022;128(15):2908\u201321.","journal-title":"Cancer"},{"key":"6733_CR29","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1002\/hed.23318","volume":"36","author":"S Dogan","year":"2014","unstructured":"Dogan S, Hedberg ML, Ferris RL, Rath TJ, Assaad AM, Chiosea SI. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population. Head Neck. 2014;36:511\u20136.","journal-title":"Head Neck"},{"key":"6733_CR30","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/j.ijrobp.2013.11.246","volume":"88","author":"MH Stenmark","year":"2014","unstructured":"Stenmark MH, McHugh JB, Schipper M, et al. Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis. Int J Radiat Oncol Biol Phys. 2014;88:580\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6733_CR31","doi-asserted-by":"crossref","unstructured":"Wan X, Liu Y, Peng Y, et al. Primary and orthotopic murine models of nasopharyngeal carcinoma reveal molecular mechanisms underlying its malignant progression. Adv Sci (Weinh). 2024;11(36):e2403161.","DOI":"10.1002\/advs.202403161"},{"key":"6733_CR32","doi-asserted-by":"crossref","unstructured":"Lv J, Xu LX, Li ZX et al. Longitudinal on-treatment circulating tumor DNA as a biomarker for real-time dynamic risk monitoring in cancer patients: The EP-SEASON study. Cancer Cell. 2024;42:1401-14.e1404.","DOI":"10.1016\/j.ccell.2024.07.001"},{"issue":"8","key":"6733_CR33","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/ijc.34154","volume":"151","author":"Q Wang","year":"2022","unstructured":"Wang Q, Xie H, Li Y, et al. Racial and ethnic disparities in nasopharyngeal cancer with an emphasis among Asian Americans. Int J Cancer. 2022;151(8):1291\u2013303.","journal-title":"Int J Cancer"},{"issue":"1","key":"6733_CR34","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2024.2425066","volume":"56","author":"LF Guo","year":"2024","unstructured":"Guo LF, Hong JG, Wang RJ, et al. Nasopharyngeal carcinoma survival by histology in endemic and non-endemic areas. Ann Med. 2024;56(1): 2425066.","journal-title":"Ann Med"},{"key":"6733_CR35","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/hed.25450","volume":"41","author":"M Ruuskanen","year":"2019","unstructured":"Ruuskanen M, Irjala H, Minn H, et al. Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: a nationwide study in Finland. Head Neck. 2019;41:349\u201357.","journal-title":"Head Neck"},{"key":"6733_CR36","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.ejca.2021.09.005","volume":"159","author":"P Bossi","year":"2021","unstructured":"Bossi P, Trama A, Bernasconi A, et al. Nasopharyngeal cancer in non-endemic areas: impact of treatment intensity within a large retrospective multicentre cohort. Eur J Cancer. 2021;159:194\u2013204.","journal-title":"Eur J Cancer"},{"key":"6733_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2023.106655","volume":"148","author":"J Neo","year":"2024","unstructured":"Neo J, Yip PL, Ong EHW, et al. Longitudinal post-radiotherapy plasma Epstein-Barr virus DNA trends inform on optimal risk stratification in endemic nasopharyngeal carcinoma. Oral Oncol. 2024;148: 106655.","journal-title":"Oral Oncol"},{"key":"6733_CR38","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1002\/cam4.3669","volume":"10","author":"W Li","year":"2021","unstructured":"Li W, Chen J, Liang B, et al. Long-term monitoring of dynamic changes in plasma EBV DNA for improved prognosis prediction of nasopharyngeal carcinoma. Cancer Med. 2021;10:883\u201394.","journal-title":"Cancer Med"},{"key":"6733_CR39","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41416-019-0575-6","volume":"121","author":"JM Nicholls","year":"2019","unstructured":"Nicholls JM, Lee VH, Chan SK, et al. Negative plasma Epstein-barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes. Br J Cancer. 2019;121:690\u20138.","journal-title":"Br J Cancer"},{"key":"6733_CR40","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.ijrobp.2017.03.018","volume":"98","author":"KY Kim","year":"2017","unstructured":"Kim KY, Le QT, Yom SS, et al. Clinical utility of epstein-barr virus DNA testing in the treatment of nasopharyngeal carcinoma patients. Int J Radiat Oncol Biol Phys. 2017;98:996\u20131001.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"6733_CR41","doi-asserted-by":"crossref","unstructured":"Le QT, Yom SS, Ng RHW, et al. In reply to Zoto Mustafayev and Ozyar. Int J Radiat Oncol Biol Phys. 2017;99:1307.","DOI":"10.1016\/j.ijrobp.2017.08.036"},{"key":"6733_CR42","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.7150\/jca.26770","volume":"10","author":"S Yang","year":"2019","unstructured":"Yang S, Zhao K, Ding X, et al. Prognostic significance of hematological markers for patients with nasopharyngeal carcinoma: a meta-analysis. J Cancer. 2019;10:2568\u201377.","journal-title":"J Cancer"},{"issue":"16","key":"6733_CR43","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1182\/blood-2015-09-672030","volume":"127","author":"JA Kanakry","year":"2016","unstructured":"Kanakry JA, Hegde AM, Durand CM, et al. The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. Blood. 2016;127(16):2007\u201317.","journal-title":"Blood"},{"key":"6733_CR44","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/cancers15020390","volume":"15","author":"T Nagahara","year":"2023","unstructured":"Nagahara T, Sugihara T, Kihara T, et al. The characteristics and prognosis of Alpha-fetoprotein and Des-gamma-carboxy prothrombin double-negative hepatocellular carcinoma at baseline in higher BCLC stages. Cancers. 2023;15:390.","journal-title":"Cancers"}],"container-title":["BMC Oral Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-06733-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12903-025-06733-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12903-025-06733-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T20:22:35Z","timestamp":1757449355000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcoralhealth.biomedcentral.com\/articles\/10.1186\/s12903-025-06733-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,23]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6733"],"URL":"https:\/\/doi.org\/10.1186\/s12903-025-06733-5","relation":{},"ISSN":["1472-6831"],"issn-type":[{"value":"1472-6831","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,23]]},"assertion":[{"value":"23 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The reporting of this study conforms to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. This study was approved by the Ethics Committee of Fujian Cancer Hospital (No. K2024-311-01). Due to the retrospective design, no additional informed consent from patients was required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1361"}}